See where relevant activity, providers, facilities, and commercial concentration exist before allocating resources.
Healthcare intelligence for commercial growth
See where the opportunity is—and what to do next.
Understand markets, prioritize territories, and identify the physicians, facilities, and accounts most relevant to your commercial strategy.
Powered by a governed national healthcare intelligence foundation.
Commercial decision path
From market signal to clear action
- 01
Where to competeMarket and geographic opportunity
- 02
Where to focusTerritory and account priority
- 03
Who mattersRelevant facilities and physicians
- 04
Why it mattersEvidence and context behind the decision
Market → Territory → Account → Physician → Evidence → Action
Commercial clarity
Turn market complexity into a clear plan of action.
Healthcare markets are fragmented across physicians, facilities, systems, procedures, affiliations, and changing commercial conditions. The platform brings those signals together so teams can decide where to focus, which accounts deserve attention, and what evidence supports the decision.
Compare markets and accounts so field coverage and commercial investment go where they can matter most.
Find the physicians, facilities, and organizations most relevant to a product, procedure category, or growth strategy.
Give leaders and field teams a shared commercial view for planning, preparation, and execution.
One connected commercial view
Move from market signal to commercial action.
- 1Market
Understand where relevant activity and provider concentration exist.
- 2Territory
Organize opportunity into practical geographic coverage.
- 3Facility
See the account and organizational context behind the market.
- 4Physician
Identify relevant providers and observed activity.
- 5Evidence
Inspect freshness, context, and important limitations.
- 6Action
Use the intelligence to plan, prioritize, and prepare.
Product in action
Move from market opportunity to the accounts and physicians behind it.
Explore a controlled specialty cohort, narrow to relevant providers, and inspect the activity, facility context, and evidence behind each profile.
Provider and account intelligence
Roy Masami Fujitani
General Surgery · NPI 1164429015
333 CITY BLVD W, SUITE 700, ORANGE, CA, 928682903
Identity matchedActivity through 2024
Commercial relevance
Observed activity across 5 reporting yearsFacility context available8 evidence domains represented
These indicators summarize the evidence available for this profile. They support prioritization and preparation; they do not predict commercial success.
Observed activity2.6K2020–2024 observed
Facility context1source reported
Evidence coverage8of 10 domains
Latest reporting year2024historical evidence
Observed healthcare activity
2020–2024Historical activity relevant to this profile
Historical observed activity. Coverage and reporting limitations are explained in the scope notes.
What this tells you
The trend shows the activity observed for this profile across the available reporting years. Use it as one input to market and account prioritization—not as total or real-time volume.
- Latest year
- 2024
- Latest observed activity
- 552
Commercial workflows
Built for the decisions that shape launch and growth.
Use the platform to move from market uncertainty to a clearer commercial plan—before launch, while building the team, and as coverage expands.
Identify the markets, facilities, and physicians most relevant to your product before commercial deployment begins.
Build territories around opportunity and determine where field coverage is most likely to matter.
Surface whitespace, revisit account coverage, and focus resources where growth potential appears strongest.
Give commercial leaders and representatives a shared view of the accounts, people, and evidence behind the plan.
The current demonstration uses a controlled procedure-driven cohort. The platform is designed for national, multi-specialty expansion.
Built to scale nationally
A national foundation behind every controlled view.
The demonstration is intentionally bounded. The underlying foundation is national, isolated, and not connected to this website.
9.6M+provider identity links
122M+structured healthcare facts
2020–2024five years of physician activity represented
3,311outpatient facilities represented
116,799outpatient hospital service records standardized
Intelligence you can inspect
Know why it matters. Know how current it is. Know what is uncertain.
Important insights retain the context needed to use them responsibly. Evidence, freshness, and limitations remain attached to the intelligence behind the decision.
Developed with direct input from MedTech field sales, commercial leadership, and healthcare-data practitioners. The platform reflects real-world commercial workflows, including territory design, account prioritization, physician targeting, hospital access, and field execution.
Reasoning attached
See the factors and evidence behind an account, facility, or provider view rather than relying on an unexplained score.
Freshness visible
Important intelligence carries a reporting period or age indicator so the team knows when the evidence was observed.
Uncertainty preserved
Observed facts, reviewed evidence, and future model-generated recommendations remain distinct. When the evidence is insufficient, the platform should say so.
Platform evolution
From market insight to coordinated commercial action.
Each product stage expands what commercial teams can see, prioritize, and act on. Future capabilities remain clearly labeled until they are available.
See the market and understand the account
Connect provider, facility, historical activity, affiliation, and evidence context inside controlled profiles and market views.
- Provider and facility intelligence
- Historical activity and account context
- Evidence, freshness, and scope indicators
Prioritize territories and targets
Organize markets, facilities, and physicians into practical commercial views for launch planning, territory design, and account preparation.
- Territory and target views
- Market and whitespace analysis
- Facility and device context as validated
Act through connected workflows
Add licensed higher-frequency data, customer-approved context, integrations, alerts, governed APIs, and evidence-grounded assistance when rights and readiness support them.
- Customer context and integrations
- Change monitoring and governed API access
- Evidence-grounded workflows and AI
Scope and interpretation
The current demonstration uses controlled, historical healthcare evidence. It does not represent complete, real-time, all-payer, or exact named-facility procedure volume. Future licensed data layers will be labeled separately when available and validated.
Full methodology and scope notes
- This is a bounded 12-physician demonstration, not national publication or a customer API.
- Identity joins use exact NPI only; no name, address, fuzzy, or web-derived identity matching is used.
- Procedure activity is annual, historical Traditional Medicare fee-for-service evidence. It is not all-payer, quarterly, real-time, total procedure volume, or proof of a named procedure facility.
- Missing or suppressed source activity is not zero.
- Facility affiliations are source-reported relationships and do not prove that a procedure occurred at the named facility.
- Open Payments records are CMS-reported transfers of value and do not by themselves prove influence, prescribing, product use, wrongdoing, or procedure activity.
- Phone, fax, email, embedded raw source records, Humacyte web observations, and official HCPCS/CPT descriptions are excluded. Five-digit numeric CPT code values are withheld; only alpha-leading HCPCS Level II values are retained.
- Withheld-code aggregates sum source-row service counts and use service-count-weighted payment averages. Their observation counts are source rows, not claims, encounters, patients, procedure episodes, or unique procedures.
Clearer market decisions start here
See where your commercial team should focus next.
Explore how the platform connects markets, territories, accounts, physicians, and evidence into a clearer plan of action.
Review the Platform Vision